Nrf2 acts as a prosurvival factor through the expression of its cytoprotective target genes, and molecular deregulation of either Nrf2 or Keap1 is widely described in lung cancer, such as Notch family impairment. The gene discussed is NFE2L2; the disease is lung carcinoma.